BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 10385529)

  • 1. The dynamics of protein kinase B regulation during B cell antigen receptor engagement.
    Astoul E; Watton S; Cantrell D
    J Cell Biol; 1999 Jun; 145(7):1511-20. PubMed ID: 10385529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterologous regulation of chemokine receptor signaling by the lipid phosphatase SHIP in lymphocytes.
    Wain CM; Westwick J; Ward SG
    Cell Signal; 2005 Oct; 17(10):1194-202. PubMed ID: 16038794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Partially distinct molecular mechanisms mediate inhibitory FcgammaRIIB signaling in resting and activated B cells.
    Brauweiler A; Tamir I; Marschner S; Helgason CD; Cambier JC
    J Immunol; 2001 Jul; 167(1):204-11. PubMed ID: 11418650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FcγRIIB-Independent Mechanisms Controlling Membrane Localization of the Inhibitory Phosphatase SHIP in Human B Cells.
    Pauls SD; Ray A; Hou S; Vaughan AT; Cragg MS; Marshall AJ
    J Immunol; 2016 Sep; 197(5):1587-96. PubMed ID: 27456487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FcgammaRIIb-mediated negative regulation of BCR signalling is associated with the recruitment of the MAPkinase-phosphatase, Pac-1, and the 3'-inositol phosphatase, PTEN.
    Brown KS; Blair D; Reid SD; Nicholson EK; Harnett MM
    Cell Signal; 2004 Jan; 16(1):71-80. PubMed ID: 14607277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The SH2 domain-containing inositol 5'-phosphatase (SHIP) recruits the p85 subunit of phosphoinositide 3-kinase during FcgammaRIIb1-mediated inhibition of B cell receptor signaling.
    Gupta N; Scharenberg AM; Fruman DA; Cantley LC; Kinet JP; Long EO
    J Biol Chem; 1999 Mar; 274(11):7489-94. PubMed ID: 10066815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PI(3,4,5)P3 and PI(3,4)P2 levels correlate with PKB/akt phosphorylation at Thr308 and Ser473, respectively; PI(3,4)P2 levels determine PKB activity.
    Ma K; Cheung SM; Marshall AJ; Duronio V
    Cell Signal; 2008 Apr; 20(4):684-94. PubMed ID: 18249092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The inositol phosphatase SHIP inhibits Akt/PKB activation in B cells.
    Aman MJ; Lamkin TD; Okada H; Kurosaki T; Ravichandran KS
    J Biol Chem; 1998 Dec; 273(51):33922-8. PubMed ID: 9852043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targets of B-cell antigen receptor signaling: the phosphatidylinositol 3-kinase/Akt/glycogen synthase kinase-3 signaling pathway and the Rap1 GTPase.
    Gold MR; Ingham RJ; McLeod SJ; Christian SL; Scheid MP; Duronio V; Santos L; Matsuuchi L
    Immunol Rev; 2000 Aug; 176():47-68. PubMed ID: 11043767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The B cell antigen receptor regulates the transcriptional activator beta-catenin via protein kinase C-mediated inhibition of glycogen synthase kinase-3.
    Christian SL; Sims PV; Gold MR
    J Immunol; 2002 Jul; 169(2):758-69. PubMed ID: 12097378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The B cell antigen receptor activates the Akt (protein kinase B)/glycogen synthase kinase-3 signaling pathway via phosphatidylinositol 3-kinase.
    Gold MR; Scheid MP; Santos L; Dang-Lawson M; Roth RA; Matsuuchi L; Duronio V; Krebs DL
    J Immunol; 1999 Aug; 163(4):1894-905. PubMed ID: 10438924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence that SHIP-1 contributes to phosphatidylinositol 3,4,5-trisphosphate metabolism in T lymphocytes and can regulate novel phosphoinositide 3-kinase effectors.
    Freeburn RW; Wright KL; Burgess SJ; Astoul E; Cantrell DA; Ward SG
    J Immunol; 2002 Nov; 169(10):5441-50. PubMed ID: 12421919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD28 costimulation mediates down-regulation of p27kip1 and cell cycle progression by activation of the PI3K/PKB signaling pathway in primary human T cells.
    Appleman LJ; van Puijenbroek AA; Shu KM; Nadler LM; Boussiotis VA
    J Immunol; 2002 Mar; 168(6):2729-36. PubMed ID: 11884439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A role for the actin cytoskeleton in the hormonal and growth-factor-mediated activation of protein kinase B.
    Peyrollier K; Hajduch E; Gray A; Litherland GJ; Prescott AR; Leslie NR; Hundal HS
    Biochem J; 2000 Dec; 352 Pt 3(Pt 3):617-22. PubMed ID: 11104665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two distinct waves of membrane-proximal B cell antigen receptor signaling differentially regulated by Src homology 2-containing inositol polyphosphate 5-phosphatase.
    Krahn AK; Ma K; Hou S; Duronio V; Marshall AJ
    J Immunol; 2004 Jan; 172(1):331-9. PubMed ID: 14688341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of B cell receptor-mediated activation of primary human B cells by coengagement of CD19 and FcgammaRIIb with Fc-engineered antibodies.
    Chu SY; Vostiar I; Karki S; Moore GL; Lazar GA; Pong E; Joyce PF; Szymkowski DE; Desjarlais JR
    Mol Immunol; 2008 Sep; 45(15):3926-33. PubMed ID: 18691763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B cell antigen receptor (BCR)-mediated formation of a SHP-2-pp120 complex and its inhibition by Fc gamma RIIB1-BCR coligation.
    Nakamura K; Cambier JC
    J Immunol; 1998 Jul; 161(2):684-91. PubMed ID: 9670943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Essential role for protein kinase B (PKB) in insulin-induced glycogen synthase kinase 3 inactivation. Characterization of dominant-negative mutant of PKB.
    van Weeren PC; de Bruyn KM; de Vries-Smits AM; van Lint J; Burgering BM
    J Biol Chem; 1998 May; 273(21):13150-6. PubMed ID: 9582355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bilevel control of B-cell activation by the inositol 5-phosphatase SHIP.
    Brauweiler AM; Tamir I; Cambier JC
    Immunol Rev; 2000 Aug; 176():69-74. PubMed ID: 11043768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The inositol polyphosphate 5-phosphatase ship is a crucial negative regulator of B cell antigen receptor signaling.
    Liu Q; Oliveira-Dos-Santos AJ; Mariathasan S; Bouchard D; Jones J; Sarao R; Kozieradzki I; Ohashi PS; Penninger JM; Dumont DJ
    J Exp Med; 1998 Oct; 188(7):1333-42. PubMed ID: 9763612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.